Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

8.ICP1-gxcbKsA0wyIrl2mL8O3XndAC91tmFCliPSlPpU.Z2rFtz4IGv03tEbNxSSUXan1Ni0EerM8-gWR_ZvfT9ZGcYGfXiknkk2-WQ~c19c051aa06b6e03de75eddf45265247
04:32pm AstraZeneca PLC : Gets a Buy rating from UBS ZD
04:17pm Oddo BHF cuts Safestore to neutral, cuts target AN
02:40pm AstraZeneca PLC : Buy rating from Jefferies ZD
02:25pm AstraZeneca PLC : JP Morgan keeps its Buy rating ZD
01:00pm AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down MT
09-16 Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says MT
09-15 Deutsche Bank Upgrades AstraZeneca to Hold, Lifts PT MT
09-15 Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating MT
09-15 Berenberg Maintains AstraZeneca at Buy as Pipeline Success Offsets Recent Setbacks; Price Target Down MT
09-15 Berenberg likes GSK; Deutsche Bank lifts Astra AN
09-15 AstraZeneca PLC : Berenberg keeps its Buy rating ZD
09-15 AstraZeneca PLC : Deutsche Bank withdraws its Sell rating ZD
09-14 AstraZeneca PLC : JP Morgan reiterates its Buy rating ZD
09-14 AstraZeneca PLC : Jefferies reiterates its Buy rating ZD
09-11 Berenberg Notes AstraZeneca's 'Stellar' Tozorakimab Late-stage Data; Buy Retained MT
09-10 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
09-10 AstraZeneca PLC : Berenberg reiterates its Buy rating ZD
09-09 RBC Capital Markets Initiates AstraZeneca Coverage at Outperform MT
09-09 RBC Initiates AstraZeneca at Outperform With GBP145 Price Target MT
09-09 RBC prefers Astra to GSK; HSBC cuts Burberry AN
09-09 RBC Initiates AstraZeneca at Outperform as Near-term Overhangs Create 'Attractive' Entry Point MT
09-09 AstraZeneca PLC : Gets a Buy rating from RBC ZD
09-08 AstraZeneca PLC : Buy rating from JP Morgan ZD
09-08 AstraZeneca PLC : Receives a Sell rating from Deutsche Bank ZD
09-08 Jefferies raises Autotrader and Rightmove AN

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.61%
+4.01%
+5.92%
+3.88%
+10.12%
+29.67%
+3.3%
+12.42%
+8.1%
Average +10.45%
Weighted average by Cap. +10.72%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
163.39USD
Average target price
210.56USD
Spread / Average Target
+28.87%
High Price Target
273.17USD
Spread / Highest target
+67.19%
Low Price Target
151.95USD
Spread / Lowest Target
-7.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!